Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TADA3 |
| Upstream (Parents) |
|---|
| (<<) CUX2 → TADA3 |
| (<<) HOXD11 → TADA3 |
| (<<) HOXD4 → TADA3 |
| (<<) SOX2 → TADA3 |
| (<<) NPAS1 → TADA3 |
| (<<) HEY1 → TADA3 |
| (<<) PAX4 → TADA3 |
| (<<) SOX9 → TADA3 |
| (<<) ZNF81 → TADA3 |
| (<<) YY1 → TADA3 |
| (<<) C11orf9 → TADA3 |
| (<<) MLLT10 → TADA3 |
| (<<) PURA → TADA3 |
| (<<) ZNF45 → TADA3 |
| (<<) HOXC4 → TADA3 |
| (<<) BCL11B → TADA3 |
| Downstream (Children) |
|---|
| TADA3 → ST18 (>>) |
| TADA3 → SP140 (>>) |
| TADA3 → MYF6 (>>) |
| TADA3 → RUNX2 (>>) |
| TADA3 → BARX1 (>>) |
| TADA3 → MYF5 (>>) |
